About Remus Pharmaceuticals Limited
Data last updated: 15 July 2026
Remus Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in wholesale trading and distribution, a part of the broader trading and commerce sector. Incorporated on 21 September 2015, the company has been in operation for over 11 years.
Registered with ROC Ahmedabad under CIN L24232GJ2015PLC084536. Listed.
Capital: an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹11.78 Cr. It is led by directors including Swapnil Jatinbhai Shah and Anar Swapnil Shah.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Jayantilal Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹625.34 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 34 employees as per the latest available data.
The company is associated with 1 brand - Remus Pharma. As per MCA filings, the company has open charges of ₹15.66 Cr and satisfied charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website remuspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address1101 To 1103 South Tower One 42 B/H Ashok Vatika Nr.Jayantilal Park Brts Ambli Bopal Roa, D, Ahmedabad, Gujarat, India – 380054
-
IndustryTrading, Wholesale, Other Wholesale
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24232GJ2015PLC084536, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24232GJ2015PLC084536 | Current |
| U24232GJ2015PLC084536 | Previous |
| U24232GJ2015PTC084536 | Previous |
Associated Brands with Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited operates one associated brand: Remus Pharma. These brands represent Remus Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Remus Pharma is engaged in providing healthcare solutions globally. | remuspharma.com |
Competitors & Alternatives of Remus Pharmaceuticals Limited
Brands and companies operating in the same space as Remus Pharmaceuticals Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Dotmatics
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Matchpoint Therapeutics
|
Small molecule medicine development and analytics services are provided. | Cambridge, United States, United States | 2021 |
Lindus Health
|
Contract-based clinical trials and recruitment services are provided. | London, United Kingdom, United Kingdom | 2021 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Business Activity of Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Remus Pharmaceuticals Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is audited by Parikh & Majmudar for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Parikh & Majmudar | Locked | Locked | Locked |
Complete auditor history for Remus Pharmaceuticals Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is currently managed by 7 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Jatinbhai Shah | Director | 21 Sep 2015 | 10 Years 11 Months | Current |
|
Anar Swapnil Shah
Also directs:
Remus Pharmaceuticals Limited, Espee Global Clinical Trial Services Private Limited, Espee Therapeutics Llp and 5 more
|
Director | 30 Dec 2020 | 5 Years 7 Months | Current |
|
Roma Vinodbhai Shah
Also directs:
Remus Pharmaceuticals Limited, Relius Lifesciences Private Limited
|
Whole-Time Director | 21 Sep 2015 | 10 Years 11 Months | Current |
|
Vishrut Chandramauli Pathak
Also directs:
Indus Valley Research Llp, Pi Square Bridge Way Advisors Llp, Pi Square Bridge Way Long Short Fund (Ifsc) Llp and 5 more
|
Director | 06 Jan 2023 | 3 Years 7 Months | Current |
|
Arpit Deepakkumar Shah
Also directs:
Remus Pharmaceuticals Limited, Senores Pharmaceuticals Limited, Ratnatris Pharmaceuticals Private Limited and 1 more
|
Managing Director | 21 Sep 2015 | 10 Years 11 Months | Current |
| Balwant Purohit | Director | 06 Jan 2023 | 3 Years 7 Months | Current |
Financials of Remus Pharmaceuticals Limited FY 2025 filings available
Remus Pharmaceuticals Limited reported revenue of ₹625.34 Cr (up 190.00% YoY) for FY 2025.
Ten-year financial statements for Remus Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Remus Pharmaceuticals Limited
Shareholding and ownership data for Remus Pharmaceuticals Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Remus Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2025 | Others | ₹49.9 Lakh | Open |
| 26 Sep 2025 | Hdfc Bank Limited | ₹10.48 Cr | Open |
| 26 Jun 2025 | Hdfc Bank Limited | ₹2.19 Cr | Open |
| 02 Sep 2024 | Hdfc Bank Limited | ₹1 Cr | Open |
| 26 Feb 2024 | Hdfc Bank Limited | ₹1.5 Cr | Open |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited has a workforce of 34 employees as of Apr 07, 2024.
Employee and EPFO history for Remus Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Remus Pharmaceuticals Limited
GST registrations and filing compliance for Remus Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Remus Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Remus Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Remus Pharmaceuticals Limited
MSME payment history for Remus Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Remus Pharmaceuticals Limited
Corporate group structure for Remus Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Remus Pharmaceuticals Limited
MCA filings and documents for Remus Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Remus Pharmaceuticals Limited
Frequently Asked Questions about Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an active public limited company in the trading sector based in Ahmedabad, Gujarat, India. It was incorporated on 21 September 2015 (11+ years old) and is registered under CIN L24232GJ2015PLC084536. The company has 34 employees.
Remus Pharmaceuticals Limited reported revenue of ₹625.34 Cr for FY 2025 (up 190.00% YoY).
The current directors of Remus Pharmaceuticals Limited are:
- Swapnil Jatinbhai Shah - Director
- Anar Swapnil Shah - Director
- Roma Vinodbhai Shah - Whole-Time Director
- Vishrut Chandramauli Pathak - Director
- Arpit Deepakkumar Shah - Managing Director
- Balwant Purohit - Director
- Sanjana Sanjeev Shah - Director
The primary industry of Remus Pharmaceuticals Limited is trading. The company specifically operates in wholesale. The company is currently active in this sector.
Yes, Remus Pharmaceuticals Limited is a listed company.
Remus Pharmaceuticals Limited can be reached at the registered office: 1101 To 1103 South Tower One 42 BH Ashok Vatika Nr.Jayantilal Park Brts Ambli Bopal Roa, D, Ahmedabad, Gujarat, India – 380054, or through the website remuspharma.com.